MGTA
Magenta Therapeutics Inc
Halal Rating :
Last Price
$20.06
Last updated:
Market Cap
-
7D Change
-12.93%
1 Year Change
22.32%
Company Overview
Exchange
Next Earnings Date
Magenta Therapeutics Inc is a clinical-stage biotechnology company developing novel medicines designed to bring the curative power of stem cell transplant to more patients. The company focuses on developing therapies to transform stem cell transplants for patients with autoimmune diseases, blood cancers, and genetic diseases.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $2.17m | $32.07m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $1.86m | $24.07m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $874000.0 | $18.72m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Magenta Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.